Optical imaging of induced signals in vivo under ambient light conditions

• US 7,668,587 B2
• Filed: 05/13/2003
• Issued: 02/23/2010
• Est. Priority Date: 06/15/2000
• Status: Active Grant

• Current Assignee: JB IP Acquisitions LLC
• Original Assignee: Spectros Corporation (AliphCom Corp.)
• Inventors: Parachikov, Ilian H., Talmi, Yair, Benaron, David A.
• Primary Examiner(s): Casler; Brian
• Assistant Examiner(s): Mehta; Parikha S
• Application Number:
  US10/437,670
• Publication Number:
  US 20040010192A1
• Time in Patent Office: 2,478 Days
• Field of Search: 600/473, 600475- 78, 600/427, 600/431, 600/439, 382/128, 382/130, 356/456, 356/433, 356/364, 250/339.02, 250/461.2, 378/4, 378/21, 378/63, 378/65, 424/9.6, 424/9.61
• US Class Current: 600/476
• CPC Class Codes: A61B 2503/40 Animals
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/0091 for mammography
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes
• CPC Class Codes: A61B 5/4381 Prostate evaluation or disorder diagnosis
• CPC Class Codes: A61B 5/7285 for synchronising or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal A61B6/5205, A61B6/541, A61B8/5207, A61B8/543 take precedence
• CPC Class Codes: B82Y 10/00 Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
• CPC Class Codes: B82Y 20/00 Nanooptics, e.g. quantum optics or photonic crystals
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

A method for detecting and localizing a target tissue within the body in the presence of ambient light in which an optical contrast agent is administered and allowed to become functionally localized within a contrast-labeled target tissue to be diagnosed. A light source is optically coupled to a tissue region potentially containing the contrast-labeled target tissue. A gated light detector is optically coupled to the tissue region and arranged to detect light substantially enriched in target signal as compared to ambient light, where the target signal is light that has passed into the contrast-labeled tissue region and been modified by the contrast agent. A computer receives signals from the detector, and passes these signals to memory for accumulation and storage, and to then to image processing engine for determination of the localization and distribution of the contrast agent. The computer also provides an output signal based upon the localization and distribution of the contrast agent, allowing trace amounts of the target tissue to be detected, located, or imaged. A system for carrying out the method is also described.

Claims

1. A method for targeting an invasive medical device or instrument toward a target location in a living subject, after a contrast agent is administered to the living subject so as to have achieved distribution and localization within the subject, comprising:

(a) performing an invasive medical or surgical procedure upon the subject using a medical device or instrument;

(b) illuminating the subject with ambient light and light from a light source, wherein a modified light is generated after interaction with and modification of the light by said contrast agent in vivo;

(c) gating a time-gated light imager wherein said gating is performed such that the imager detects light substantially enriched in the modified light while substantially rejecting the ambient light;

(d) detecting the modified light with said gated imager;

(e) determining a present status of the medical device or instrument with respect to said target location based upon the detected modified light; and

(f) generating an output signal in response to said determination.

2. The method of claim 1, wherein said output signal comprises a location of the medical device or instrument.

3. The method of claim 1, wherein said output signal comprises the efficacy of a therapeutic intervention.

4. The method of claim 1, wherein said medical device or instrument comprises a prostate biopsy needle, said target location comprises a potential prostate cancer site, and said optical contrast agent is targeted to cancer-influenced prostate cell surface antigens,

and wherein in step (d) said modified light is detected after passage of the light through an opaque region of the body of said subject and after interaction with and modification of the light by said contrast agent, the method further comprising:

(g) positioning the biopsy needle at an identified potential cancer site and collecting a biopsy sample at that site; and

(h) repeating steps (d) through (g) until a sufficient number of prostate biopsy samples have been collected.

5. A system for targeting an invasive medical device or instrument toward a target location in a living subject illuminated by ambient light, after a contrast agent is administered to the living subject so as to have achieved distribution and localization within the subject, and where the system does not include said living subject, the system comprising:

(a) a light emitter configured to illuminate a portion of the subject with illuminating radiation, and said administered contrast agent potentially disposed to interact with and modify said illuminating radiation;

(b) a gated light collector configured to collect a portion of the modified illuminating radiation, said collected portion having passed through an opaque region of the body of the subject and said collector optically coupled to the body, wherein the gated light collector is configured to detect light substantially enriched in said modified illuminating radiation, and to substantially reject said ambient light, and to provide a detected signal in response to said collected portion;

(c) a medical device or instrument configured to perform an invasive procedure;

(d) means for determining a positional estimate of the present location of said medical device or instrument with respect to a target location based upon said detected signal, said determination is based upon a measurement function of said distribution and localization of said contrast agent in relation to a position of said medical device or instrument; and

(e) means for producing an output signal in response to said determination.

6. The system of claim 5, wherein said positional estimate is a function of the accuracy of placement of a probe at said target location.

7. The system of claim 6, wherein said function of the accuracy of placement is a true or false indication as to whether or not the probe is accurately placed.

8. The system of claim 5, wherein said positional estimate is a direction of a target tissue of said target location.

9. The system of claim 5, wherein said positional estimate is a distance to a target tissue of said target location.

10. The system of claim 5, wherein said positional estimate is a localization of said medical device or instrument with respect to tissue type.

11. The system of claim 5, wherein:

said contrast agent comprises a fluorescent contrast agent targeted to cancer-specific surface antigens for providing a source of contrast between prostate cancer cells and normal prostate tissues, said agent ingested orally and systemically absorbed so as to have achieved distribution and localization within the prostate;

said light emitter comprises a monochromatic intensity modulated light source for illuminating the prostate with illuminating radiation, said distributed contrast agent at least potentially disposed to fluoresce in response to said illuminating radiation;

said gated light collector comprises a multi-element light collector for collecting a portion of said fluorescent radiation after having passed through an opaque region of the prostate and modified by the contrast agent, said multi-element light collector providing a detected signal in response to said collected portion;

said medical instrument comprises a medical ultrasound probe for rectal use during said prostate examination, said medical probe coupled to said light emitter, said light collector, or both; and

the system further comprises;

(i) means for determining the presence and location of prostate cancer based upon said detected signal; and

(ii) means for generating an output image related to a distribution and localization of said contrast agent in response to said determination.